NASDAQ (USD): Bio-Path Holdings, Inc. (BPTH)
Last Price
1.49
Today's Change
+0.821 (122.72%)
Day's Change
1.33 - 3.39
Trading Volume
112,449,605
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump Transition Team Plans Sweeping Rollback of Biden's EV, Emissions Policies
2
TikTok Turns to US Supreme Court in Last-ditch Bid to Avert Ban
3
US Senate advances Massive Defence Bill, Despite Transgender Provision
4
Booking CFO Says Inflation Impact Still Curbing US Travel Demand
5
US Retail Sales Beat Expectations in November
#
Stock
Score
TNXP
Tonix Pharmaceuticals Holding Corp.
NVDA
NVIDIA Corporation
800
AGN
750
TSLA
Tesla, Inc.
AVGO
Broadcom Inc.
6
BTE
Baytex Energy Corp.
500
7
BRO
Brown & Brown, Inc.
8
ADBE
Adobe Inc.
9
TYL
Tyler Technologies, Inc.
10
NOC
Northrop Grumman Corporation
Last
Change
Volume
0.57
+0.205
699,386,546
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
UWT
0.164
-0.002
244,137,454
AGIL
0.197
+0.114
206,404,986
LYLT
0.218
204,480,452
APCX
0.62
+0.239
195,303,703
130.68
+1.77
194,479,704
ZNGA
8.18
-0.17
184,885,916
LICN
0.489
-1.631
183,350,854
BRK-A
673,274.00
+2,536.31
1,647
RTLA
209.90
+74.87
0
BH-A
1,258.73
+59.36
41
ZTRE
50.25
+50.25
19
ZTEN
49.59
+49.59
4,451
FCNCA
2,070.94
+41.58
114,191
BKNG
4,980.40
+37.05
261,791
ACSG
33.28
+33.28
99,050
EMSA
140.77
+30.77
EMLB
80.80
+30.30
MELI
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
NVR
8,101.21
-115.94
29,118
MKL
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....